Giancarlo Cortese

Author PubWeight™ 9.10^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.	Nat Commun	2012	1.41
2	The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs.	Cell Cycle	2008	1.05
3	The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses.	J Immunol	2008	0.95
4	Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease.	Brain Res	2011	0.88
5	Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.	Clin Cancer Res	2006	0.88
6	Identification of multipotent cytotrophoblast cells from human first trimester chorionic villi.	Cloning Stem Cells	2009	0.87
7	Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma.	Clin Cancer Res	2006	0.81
8	Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.	Mol Cancer	2014	0.80
9	Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.	BMC Nephrol	2011	0.80
10	Intravenous infection of virulent shigellae causes fulminant hepatitis in mice.	Cell Microbiol	2005	0.78
11	Low dose CT in early lung cancer diagnosis: Prevalence data.	Radiol Med	2006	0.75
12	Survival of a subperiosteal tantalum mesh from 1955 to 2004.	Br J Oral Maxillofac Surg	2005	0.75